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ABSTRACT
Microglial cells are the main HIV-1 targets in the cen-
tral nervous system (CNS) and constitute an import-
ant reservoir of latently infected cells. Establishment
and persistence of these reservoirs rely on the chro-
matin structure of the integrated proviruses. We
have previously demonstrated that the cellular
cofactor CTIP2 forces heterochromatin formation
and HIV-1 gene silencing by recruiting HDAC and
HMT activities at the integrated viral promoter. In
the present work, we report that the histone de-
methylase LSD1 represses HIV-1 transcription and
viral expression in a synergistic manner with CTIP2.
We show that recruitment of LSD1 at the HIV-1
proximal promoter is associated with both
H3K4me3 and H3K9me3 epigenetic marks. Finally,
our data suggest that LSD1-induced H3K4 tri-
methylation is linked to hSET1 recruitment at the
integrated provirus.
INTRODUCTION
Eukaryotic DNA is wrapped around core histone proteins
to form the chromatin (1). It is now well-established that
the local state of chromatin inﬂuences transcription. A
heterochromatin environment is more compact and
structured than euchromatin, and is therefore repressive
for transcription. On the contrary, euchromatin, a relaxed
state of chromatin, is associated with active transcription.
The compaction of chromatin and its permissivity for
transcription depend on post-translational modiﬁcations
of histones such as acetylation, methylation, sumoylation,
phosphorylation and ubiquitinylation (2). It has been pro-
posed that combination of such different covalent modiﬁ-
cations of histone proteins may constitute a histone code
and could be used to determine transcriptional status
(3,4). The acetylation of a lysine in histones is mainly
linked to gene activation, while lysine methylation can
be associated to both gene activation and repression (5).
For instance, methylation of H3K4 (Histone 3 Lysine 4),
H3K36 and H3K79 have been associated to gene activa-
tion, whereas methylation of H3K9 and H3K27 have been
linked to gene repression (6). The transcriptional activity
of a gene is also regulated by the degree of histone methy-
lation (mono, di or trimethylation). Trimethylation of
H3K4 (H3K4me3) can exist in conjunction with H3K9
acetylation and is correlated to the activation of transcrip-
tion (7,8), whereas dimethylation of H3K9 is linked to the
recruitment of the deacetylase complex Set3, which induces
gene repression (9). However, this epigenetic code is not
always correlated with a corresponding transcriptional
activity (10,11).
To date a great number of methyltransferases and
demethylases has been shown to shape the pattern of
lysine methylation. SUV39H1 has been involved in hetero-
chromatin formation at the HIV-1 promoter and, as a
consequence, in HIV silencing (12,13). The lysine speciﬁc
demethylase (LSD1), discovered in 2004 (14), was initially
associated to gene repression (15,16). This enzyme, which
removes methyl groups from mono and dimethylated
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Additional binding partners of the LSD1-CoREST
complex are histone deacetylases HDAC1 and HDAC2,
which have been linked to transcriptional repression of
several genes including the HIV-1 provirus (17).
However, LSD1 has also been involved in the activation
of transcription (18). Indeed, Metzger et al. (18) showed
that LSD1 and the androgen receptor co-localize on pro-
moters following hormone treatment. The recruitment of
these two proteins did not alter H3K4 methylation but
stimulated H3K9 demethylation, which led to transcrip-
tional activation. Since LSD1 cannot remove methyl
groups from trimethylated lysines, it has been proposed
that LSD1 could serve as an anchored protein to recruit
directly or indirectly H3K9 speciﬁc histone demethylases.
Furthermore, both LSD1 and the H3K9 demethylase
of the Jumonji-containing class belong to the same
chromatin-remodelling complex, further supporting this
hypothesis (19). However, the discovery that inhibition
of LSD1 prevents lytic replication of the herpes simplex
virus (HSV) as well as its reactivation from latency has
added another level of complexity in our understanding of
LSD1 function in gene regulation. Indeed, it was shown
that HCF-1, which is a component of the SET1 and
MLL1 H3K4 methyltransferase complexes, recruits
LSD1 and induces H3K4 trimethylation and transcrip-
tional activation of the HSV promoter (20–23). From an
elegant approach that uses a variation of genome-wide
chromatin immunoprecipitation called chromatin-
immunoprecipitation (ChIP)-DSL, it appeared that
LSD1 plays an even broader role in transcriptional acti-
vation as 80% of the 4200 LSD1-positive promoters were
associated with RNA polymerase II and gene activation
(24). These results underlined the dual role of LSD1 in
gene activation and repression, and highlighted the com-
plex role of lysine methylation in epigenetic regulation.
Here, we focused on the molecular mechanisms
underlying HIV-1 transcription. We studied in more
details the molecular mechanisms involved in the estab-
lishment and maintenance of HIV-1 latency in microglial
cells, the main HIV-1 target cells in the central nervous
system (CNS) (25). These long-lived latent reservoirs con-
stitute a major obstacle to the eradication of HIV-1.
Understanding the cell-type speciﬁc molecular mechan-
isms of establishment, maintenance and reactivation of
HIV-1 latency is therefore crucial to achieve an efﬁcient
therapeutic intervention, in which the ultimate goal is to
completely eradicate both latently and productively
infected cells (26,27). We have previously shown that
COUP-TF interacting protein 2 (CTIP2), a recently
cloned transcriptional repressor that can associate with
members of the COUP-TF family (28), inhibits HIV-1
replication in human microglial cells (29,30) by recruiting
a chromatin-modifying complex (13). Indeed, our work
showed a concomitant recruitment of histone deacetylases
HDAC1 and HDAC2, and methyltransferase SUV39H1
to the viral promoter by CTIP2. Heterochromatin
formation at the HIV-1 promoter has been linked to
post-integration latency (26,31), suggesting that transcrip-
tional repressors such as CTIP2 are involved in the estab-
lishment and maintenance of viral persistence and
post-integration latency in the brain. The co-repressor
CTIP2 has an even more pleiotropic action by regulating
the expression of host genes in the infected cell. In this
context, we have shown that CTIP2 silences p21 gene tran-
scription by inducing epigenetic modiﬁcations, such as
deacetylation and methylation of histones (32). This
effect may indirectly favour HIV-1 latency since activation
of the p21 gene stimulates viral gene transcription in
macrophages (33). Moreover, CTIP2 counteracts HIV-1
Vpr which is required for p21 expression. In a recent art-
icle, we suggested that all these factors together contribute
to HIV-1 transcriptional latency in microglial cells (32).
In the present work, we show that LSD1 represses
HIV-1 transcription and viral expression in a synergistic
manner with CTIP2. We report for the ﬁrst time that re-
cruitment of LSD1 at the HIV-1 proximal promoter is
associated with both H3K4me3 and H3K9me3 epigenetic
marks.
MATERIAL AND METHODS
Plasmids
Most of the constructs used in our assays have been
described previously: pcDNA3, pFLAG-CTIP2 (28),
pNL-4.3, pVSV.G, pRFP-CTIP2 (29), pTat-GFP (30),
pshRNALSD1, pshRNA-Control and pFLAG-LSD1
were provided by E. Metzger and R. Schule (18). The
episomal LTR-LUC, pshRNA-CTIP2, pSirenZsGreen-
shRNA-CTIP2 plasmids have also been described (13).
Cell culture
The human microglial (provided by M. Tardieu, Paris,
France) (34) and HEK 293T cell lines were maintained
in Dulbecco’s modiﬁed Eagle’s medium (DMEM) con-
taining 10% fetal calf serum and 100U/ml penicillin–
streptomycin. CTIP2 knocked-down microglial cells
expressing shRNA-CTIP2 were stably established by in-
fection of microglial cells with a pSirenZsGreen-ShRNA-
CTIP2-based retrovirus as described by the manufacturer
(Clontech Lab. Inc.). CTIP2 shRNA-expressing cells were
sorted by ﬂow cytometry for the concomitant expression
of the ZsGreen protein and cultured in DMEM. The
CTIP2 knock-down efﬁciency was controlled by western
blot and ChIP experiments. The monocytic HIV-1
infected U1 cell line was maintained in RPMI
1640-Glutamax I medium supplemented with 10% fetal
bovine serum and 50U/ml penicillin–streptomycin.
Co-immunoprecipitation assays
HEK 293T cells cultured in 100-mm diameter dishes were
transfected using the calcium phosphate co-precipitation
method with the indicated pFLAG-CTIP2 (30mg),
pFLAG-LSD1 (30mg), pSuper control or pcDNA3-
FLAG control (30mg) vectors. Two days post-
transfection, immunoprecipitations were performed using
the standard technique with M2 anti-FLAG (Sigma) over-
night at 4 C. Finally, the immunoprecipitated complexes
were processed for SDS–PAGE and western blot analysis.
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SDS–PAGE was performed using standard techniques.
Proteins were detected using antibodies directed against
the FLAG epitope (M2 mouse monoclonal from Sigma),
LSD1 (Abcam), CTIP2 (bethyl) and b-actin (Sigma).
Proteins were visualized by chemiluminescence using the
Super Signal Chemiluminescence Detection System
(Pierce).
Luciferase assays
Microglial cells cultured in 48-well plates were transfected
with the indicated vectors using the calcium phosphate
co-precipitation method. Total amounts of DNA were
normalized with the corresponding control vector. Two
days later, cells were collected and luciferase activity was
determined using the Dual-Glo
TM Luciferase Assay
System (Promega). Values correspond to an average of
at least three independent experiments performed in
triplicate.
Viral replication
Microglial cells cultured in 12-well plates were transfected
using the calcium phosphate co-precipitation method with
HIV-1 pNL-4.3 and the expression plasmids as indicated.
Total amounts of DNA were normalized with the corres-
ponding empty vector. HIV-1 replication was monitored
as described previously (30). Values correspond to an
average of at least three independent experiments carried
out in triplicate.
Pseudotyped virion production and single-round infection
The plasmid pNL-4.3-Env was co-transfected with the en-
velope plasmid encoding the pVSV.G envelope protein
into HEK 293T cells. Virions were collected 48h post-
transfection. For single-round infection, microglial cells
were incubated with the VSV-pseudotyped HIV-1
NL4.3-Env virus for 24h at 37 C.
Chromatin immunoprecipitation assays
Microglial and CTIP2 knocked-down microglial cells cul-
tured in 150-mm diameter dishes were subjected to single-
round infection by the VSV-pseudotyped viruses 24h
before being processed for ChIP experiments. HEK
293T cells cultured in 100-mm diameter dishes were trans-
fected using the calcium phosphate co-precipitation
method with the indicated vectors or the corresponding
control vectors. ChIP assays were performed using the
ChIP assay kit (Upstate) 48h post-transfection.
Microglial and U1 cells were mock-treated or treated with
PMA (100nM) for 24h before ChIP assays. The primary
antibodies used for ChIP were as follows: anti-LSD1
(Abcam), anti-CTIP2 (bethyl), anti-RNA Pol II (Santa
Cruz), anti-Sp1 (Upstate), anti-H3pan (Upstate), anti-
Ac-H3 (Upstate), anti-H3K9me3 (Upstate), antiH3K4me3
(Upstate), anti-WDR5 (Abcam) and anti-hSET1 (Abcam).
Immunoprecipitated DNA was subjected to real-time
PCR quantiﬁcation. The ampliﬁed regions of the provirus
are indicated in the legend section. The speciﬁcity of the
enrichment has been controlled by ampliﬁcations of the
GAPDH gene (13).
Indirect immunoﬂuorescence and confocal microscopy
Microglial cells cultured in 48-well plates were transfected
or not using the calcium phosphate co-precipitation
method with the pFLAG-LSD1, pRFP-CTIP2 or pTat-
GFP expression vectors. Cells were ﬁxed and permeabil-
ized as described previously (30). The cover slips were then
incubated for 1h at room temperature with primary
antibodies directed against LSD1 (Abcam), hSET1
(Abcam) or against the FLAG epitope (M2 mouse mono-
clonal; Sigma). The primary immunocomplexes were
revealed by CY3- or CY5-labeled secondary anti-species
antibodies. The stained cells were analysed by confocal
microscopy using a Zeiss laser scanning microscope
(model 510 invert) equipped with a Planapo oil (63 )
immersion lens (numerical aperture=1.4).
RESULTS
LSD1 represses HIV-1 replication and transcription in
microglial cells
The function of LSD1 in HIV-1 infected cells was
investigated by using an LSD1 knock-down strategy. We
co-transfected microglial cells with a complete HIV-1 in-
fectious provirus (pNL-4.3) and with or without a shLDS1
expressing vector. The efﬁciency of the knock-down of
LSD1 was checked by western blot (Figure 1A). As
shown in Figure 1A, the knock-down of LSD1 was
associated with a 6-fold increase in p24 production,
which argues in favour of a repressive role of LSD1 in
HIV-1 replication. We next investigated whether LSD1
has a direct impact on transcription of the HIV-1 genes
since this protein is involved in the transcriptional regula-
tion of many cellular genes. Microglial cells were trans-
fected with the episomal LTR-Luc vector with or without
the shLSD1 expressing vector in the absence (Figure 1B)
or presence (Figure 1C) of Tat. In the absence of Tat,
LSD1 repressed LTR transcriptional activity in a dose-
dependent manner (Figure 1B columns 2 and 3). When
Tat was expressed together with the shLDS1 vector, we
observed a synergistic activation of LTR-driven transcrip-
tion (Figure 1C column 4 compared to columns 2 and 3).
Thus LSD1 inhibits HIV-1 replication as a result of tran-
scriptional repression occurring at both the early
Tat-independent and the late Tat-dependent steps.
LSD1-mediated repression of HIV-1 is associated with
the epigenetic marks H3K4me3 and H3K9me3
To investigate whether LSD1 is recruited at the HIV-1
promoter in vivo, we performed ChIP assays using micro-
glial cells transfected with the pNL-4.3 provirus.
Over-expression of LSD1 was associated to an increase
of H3K9 trimethylation (H3K9me3) and more surprising-
ly to an increase of H3K4 trimethylation (H3K4me3)
(Figure 2A columns 3 and 4) in the proximal region of
the HIV-1 promoter. In agreement, knocking-down en-
dogenous LSD1 expression disfavoured H3K9 and
1906 Nucleic Acids Research, 2012,Vol.40, No. 5H3K4 trimethylation (Figure 2A columns 3 and 4).
Interestingly, knocking-down LSD1 in HIV-1 transfected
microglial cells was associated with a strong increase of
H3 global acetylation level (Figure 2A column 6) and with
a stable amount of H3 histones associated to the viral pro-
moter (Figure 2A column 5). Furthermore, knocking-
down LSD1 strongly increased the recruitment of the
RNA pol II to the HIV-1 promoter, thereby conﬁrming
the activated status of the viral promoter (Figure 2A
column 7). From these results we speculated that HIV-1
reactivation in latently infected U1 cells could be
associated with a release of LSD1 and a concomitant
decrease of H3K9 and H3K4 trimethylation levels at the
HIV-1 promoter. To test this hypothesis, histone methy-
lation marks and LSD1 recruitment at the HIV-1
promoter were monitored in the latently infected U1 cell
line after activation of viral gene transcription. As shown
in Figure 2B, PMA (phorbol-12-myristate 13-acetate)
treatment induced a release of the endogenous LSD1
from the viral promoter (column 2). Moreover, this phe-
nomenon was associated with decreased trimethylation
levels of H3K4 and H3K9 (columns 3 and 4 from
Figure 2B, respectively). As expected, the release of the
endogenous LSD1 following PMA treatment of the
latently infected U1 cell line was associated with an
increase of the global histone H3 acetylation level and
with an increased RNA pol II recruitment to the HIV-1
promoter (Figure 2B columns 6 and 7). To verify whether
LSD1 is speciﬁcally located at the promoter region of the
HIV-1 genome, we performed several ChIP experiments
with additional sets of primers hybridizing in adjacent
regions of the viral genome. As shown in Figure 2C,
LSD1 was only associated to the proximal promoter region
(columns 1 and 2) and not with adjacent regions such as
intragenic Gag or Vpr regions (columns 3 and 4).
Moreover, the epigenetic marks associated with the loss
of LSD1 we described above were also observed with
other LSD1 regulated genes since we observed the same
events with the LSD1-regulated gene CEBP alpha (Figure
2D, columns 5, 6 and 7), as previously described (35). In
accordance with the literature (36), we showed that
knock-down of LSD1 is correlated with an increase of
H3K4me3 in the promoter region of LSD1 regulated
genes such as SCN1A, SCN3A (data not shown) and
SCN2A2 (Figure 2D columns 2, 3 and 4), suggesting
that these LSD1-sensitive genes may be regulated by
molecular mechanisms linked to the previously described
enzymatic activity of LSD1. As a control, we showed that
LSD1 is not associated to the promoter of the LSD1-
insensitive gene GAPDH (Figure 2D). In addition,
H3K4 trimethylation level at the GAPDH promoter was
not sensitive to the modulation of LSD1 expression.
Taken together, these data suggest that LSD1 is re-
cruited to the HIV-1 promoter and thereby represses its
transcriptional activity. However, we were unable to show
that this repression was linked to its previously
characterized H3K4 or H3K9 demethylase activities.
LSD1 represses HIV-1 LTR-driven gene expression
through the Sp1-binding sites of HIV-1 promoter
In order to identify the LTR region allowing the LSD1-
mediated repression of HIV-1 transcription in microglial
cells, we performed transient transfection experiments
with 50 truncations or mutations of the LTR-Luciferase
Figure 1. LSD1 represses HIV-1 gene transcription and viral replication. (A) Microglial cells were transfected with the pNL-4.3 and the indicated
vectors. Culture supernatants were analysed for p24 Gag contents 48h post-transfection. (B and C) Microglial cells were transfected with the
episomal LTR-LUC and the indicated vectors. DNA amounts were normalized in all transfection assays with pshRNA-Control or
pcDNA3-FLAG control vectors. Luciferase activities were measured 2 days post-transfection and expressed relative to the value obtained with
episomal LTR-LUC alone. (A and C) The knock-down efﬁciency of sh-RNA constructs (versus sh-control) has been controlled by western blot
analysis.
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or endogenous LSD1 knock-down. While LSD1 over-
expression repressed the luciferase expression of the full-
length and the proximal LTR constructs, knocking-down
LSD1 stimulated these transcriptional activities (Figure 3A
lanes 1 and 2). Interestingly, mutation of the Sp1-binding
sites abrogated LSD1-mediated repression, suggesting the
involvement of this LTR region in LSD1 recruitment
(Figure 3A lane 3). To establish whether the endogenous
LSD1 associates with the viral promoter via the Sp1-
binding sites, we performed ChIP experiments with the
wild-type LTR-Luc (wild-type 1–789) and the Sp1-
binding sites-mutated vectors. As shown in Figure 3B
(column 3), mutation of the Sp1-binding sites abolished
LSD1 recruitment at the vial promoter. Interestingly, we
observed that the epigenetic mark H3K4me3 is preferen-
tially detected in the wild-type LTR (pLTR-Luc wt)
(Figure 3B column 4). Since it has been shown that
Figure 2. LSD1 association with the HIV-1 proximal promoter induces local trimethylation of histone 3 lysines 4 and 9. (A) ChIP experiments were
performed on microglial cells transfected with the pNL-4.3 provirus in the presence of the pFLAG-LSD1, the pshRNA-LSD1 or the respective
pcDNA3-FLAG and pshRNA-control vectors. Cells were subjected to ChIP assays with the indicated antibodies. Speciﬁc enrichments in the HIV-1
proximal promoter were quantiﬁed by real-time PCR targeting the Nuc-1 region. Speciﬁc enrichments were calculated relative to the control IgG and
relative enrichments in the context of LSD1 over-expression or depletion were expressed relative to the value obtained with the pcDNA3-FLAG or
the pshRNA-control vectors, respectively. (B) Mock-treated and PMA-treated U1 cells were subjected to ChIP experiments with the indicated
antibodies. Speciﬁc enrichments in the HIV-1 proximal promoter were quantiﬁed by real-time PCR targeting the Nuc-1 region. The amounts of
immunoprecipitated material were normalized to the input DNA and presented relative to the non speciﬁc IgG precipitation. (C) pcDNA3 and
pFLAG-LSD1 transfected microglial cells were subjected to ChIP experiments with the anti-LSD1 antibody. Speciﬁc enrichment of the NF-kB and
the Nuc-1 regions of the promoter and the Gag and Vpr intragenic regions are presented relative to the non speciﬁc enrichment obtained with the
control IgG setted at 1. (D) pshRNA-control and pshRNA-LSD1 transfected microglial cells were subjected to ChIP experiments with the indicated
antibodies. Speciﬁc enrichment of the SCN2A2, CEBPa and GAPDH promoters are indicated relative to the control IgG.
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of HDAC1 on the WT and the Sp1-mutated viral
promoter. As shown in Figure 3B, the global recruitment
of HDAC1 to the HIV-1 promoter was mostly abro-
gated by the mutation of the Sp1-binding sites (column
5). Interestingly, this was correlated with a small in-
crease of the H3 acetylation level (Figure 3B column 6)
and a strong decrease of the H3K4 trimethylation level
(Figure 3B column 4). In a control experiment, we
veriﬁed that the same amounts of histone H3 was
found on both constructs (Figure 3B column 7).
LSD1 cooperates with CTIP2 to repress HIV-1
replication and transcription
We have previously shown that CTIP2 represses HIV-1
gene transcription in microglial cells (13). We therefore
hypothesized that CTIP2 and LSD1 could cooperate to
repress HIV-1 replication and transcription. As shown in
Figure 4A, the knock-down of both factors synergistically
activated HIV-1 replication (30-fold activation with the
double knock-down compared to the 5-fold and 10-fold
activations observed with the LSD1 and CTIP2 single
knock-downs, respectively).
The transcriptional impacts of LSD1 and CTIP2
knock-downs were then assessed in the presence or absence
of Tat. Single knock-down of CTIP2 stimulated transcrip-
tion in the absence and presence of Tat (Figure 4B
columns 2 and 3 and C columns 3 and 4). However, com-
bination of LSD1 and CTIP2 knock-downs further
increased HIV-1 gene transcription in the absence or
presence of Tat (Figure 4B column 4 and 4C column 5).
These results strongly suggest a functional cooperation
between LSD1 and CTIP2 in the repression of HIV-1
transcription in a chromatinized promoter. As controls,
knock-down and over-expression efﬁciencies were veriﬁed
by western blot (Figure 4D).
LSD1 interacts with CTIP2 and co-localizes with Tat and
CTIP2 in the nucleus
Our data strongly suggest a functional cooperation be-
tween LSD1 and CTIP2. We therefore investigated
whether these proteins could interact physically. To this
end, we performed FLAG-targeted immunoprecipitation
experiments with nuclear extracts from cells expressing
FLAG-LSD1 or FLAG-CTIP2 proteins. As shown in
Figure 5A, FLAG-CTIP2 and FLAG-LSD1 co-immuno-
precipitated with endogenous LSD1 and CTIP2 proteins,
Figure 3. LSD1-mediated repression of HIV-1 gene transcription and replication requires HIV-1 proximal promoter Sp1-binding sites. (A) Microglial
cells were transfected with 1mg of the pLTR-LUC (1–789), pLTR-LUC (292789) or the pLTR-LUC (1–789) mut Sp1 and 1.5mg of the
pFLAG-LSD1 or pshRNA-LSD1 vectors. pcDNA3-FLAG and pshRNA-control plasmids were used to normalize the transfected DNA
amounts. Two days post-transfection, Luciferase activities were measured and the results are expressed relative to the control vectors. (B) HEK
293T cells were transfected with the pLTR-LUC (1–789) or with the pLTR-LUC (1–789) mut Sp1 vector 48h before being subjected to ChIP
experiments with the indicated antibodies. Input and immunoprecipitated DNAs were quantiﬁed by real-time PCR using primers targeting the
Sp1-binding sites region of the HIV-1 promoter. The amounts of immunoprecipitated material were normalized to the input DNA and results are
presented relative to the non-speciﬁc control IgG.
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these two proteins. We next investigated whether LSD1
co-localizes with Tat as previously shown for CTIP2 (30).
Cells transfected with a RFP-CTIP2 expressing vector in
the presence or not of GFP-Tat were examined for en-
dogenous LSD1 localization using confocal microscopy.
Endogenous LSD1 expression was observed in both the
cytoplasm and the nucleus (Figure 5B, pictures 4 and 6).
As previously described (13), nuclear expression of CTIP2
harboured ball-like structures (Figure 5B, pictures 7
and 9). As shown in Figure 5C (pictures 5–8), LSD1 and
CTIP2 co-localized in the CTIP2-induced nuclear struc-
tures (30), suggesting that CTIP2 relocated LSD1 into
these structures. Interestingly, GFP-Tat expression re-
located LSD1 from the cytoplasm to the nucleus
(Figure 5C, pictures 1–4). Finally, observations of the con-
comitant expressions of RFP-CTIP2 and GFP-Tat
revealed co-localization of both proteins with LSD1 in
the nucleus (Figure 5D). Staining of genomic DNA are
presented in Figure 5B. Altogether, these results support
that CTIP2 and LSD1 interact physically and that LSD1
is re-localized by CTIP2 and Tat in dense sub-nuclear
structures.
LSD1 is required for CTIP2 recruitment at the HIV-1
proximal promoter
We next asked whether LSD1 is required for CTIP2 re-
cruitment to the HIV-1 promoter. To address this ques-
tion, we performed additional ChIP experiments in the
LSD1 over-expression or LSD1 knock-down contexts.
As shown in Figure 6A, over-expression of LSD1 was
associated with an increase of endogenous CTIP2 recruit-
ment to the viral promoter. As expected, LSD1
knock-down decreased CTIP2 association with the viral
promoter (Figure 6A). To further study LSD1 and CTIP2
recruitment at the HIV-1 promoter, we performed ChIP
experiments with HIV-1 infected microglial cells express-
ing (control) or not CTIP2 (shCTIP2) (Figure 6B). As a
control, we checked that CTIP2 is less recruited onto the
HIV-1 proximal promoter in the infected shCTIP2 micro-
glial cell line (Figure 6B column 2 compared to column 1)
compared to the control cell line. Unexpectedly,
knocking-down CTIP2 slightly increased LSD1 recruit-
ment to the LTR (Figure 6B column 3). Moreover, this
recruitment was correlated with an increased H3K4
trimethylation (Figure 6B column 4). These results suggest
that LSD1 is required for CTIP2 recruitment to the HIV-1
proximal promoter.
LSD1-mediated repression and H3K4 trimethylation are
associated with the recruitment of hSET1 and WDR5
to the HIV-1 proximal promoter
The epigenetic mark H3K4me3 has been shown to be asso-
ciated with LSD1 recruitment (20,21). This association
results from the interaction of LSD1 with a methyl-
transferase complex containing WDR5 and hSET1
(20,21). ChIP experiments performed with cells over-
expressing LSD1 conﬁrmed an increased recruitment of
hSET1 and WDR5, two members of the hCOMPASS
complex (Figure 7A, blue columns 4 and 5) to the
HIV-1 promoter, together with an increased H3K4
trimethylation. Inversely, knocking-down endogenous
LSD1 decreased hSET1 and WDR5 association to the
viral promoter and H3K4 trimethylation (Figure 7A
pink columns). ChIP experiments performed with the
wt-LTR-Luc or the Sp1-mutated LTR-Luc reporter con-
structs further conﬁrmed that hSET1, WDR5 and LSD1
are recruited concomitantly to the proximal Sp1-binding
Figure 4. LSD1 cooperates with CTIP2 to repress HIV-1 gene transcription and viral replication. (A) Microglial cells were transfected with pNL-4.3
and the indicated plasmids (columns 2 to 4) or the pshRNA-control vector (column 1). Culture supernatants were analysed for p24 contents 48h
post-transfection. (B and C) Microglial cells were transfected with the episomal LTR-LUC and the indicated plasmids or the pshRNA-control vector.
Luciferase activities were measured 2 days post-transfection and expressed relative to the value obtained with the episomal LTR-LUC and the
control vectors (columns 1). DNA quantities were normalized with the pshRNA-control vector. (D) The knock-down efﬁciency of sh-RNA con-
structs was controlled by western blot analysis. The control columns 1 of the panels correspond to extracts from cells transfected with the
pshRNA-control vector.
1910 Nucleic Acids Research, 2012,Vol.40, No. 5Figure 5. LSD1 associates with CTIP2 and co-localizes with CTIP2 and Tat within nuclear structures. (A) HEK 293T cells were transfected with the
pFLAG-CTIP2, the pFLAG-LSD1 expression vectors or the control pCDNA3-FLAG vector. Complexes immunoprecipitated with the anti-FLAG
antibody were immunodetected for the presence of FLAG-CTIP2, FLAG-LSD1, endogenous LSD1 and CTIP2 proteins by western blot as
indicated. (B–D) Microglial cells were transfected with pTat-GFP or/and pRFP-CTIP2 as indicated and accessed for endogenous LSD1
immunodetection with primary anti-LSD1 antibodies. The primary immunocomplexes were revealed by CY3- or CY5-labeled secondary antibodies.
Mask columns show the co-localized staining.
Nucleic Acids Research,2012, Vol.40, No. 5 1911sites of the viral promoter. Indeed, the abrogated associ-
ation of LSD1 to the Sp1-mutated LTR (Figure 7B lane 2
column versus column) correlated with a reduced recruit-
mentofbothhSET1andWDR5(Figure7B,columns3and
4). From these results, we hypothesized that HIV-1 re-
activation in microglial cells could be associated with a
release of LSD1 and an alongside reduced recruitment of
hSET1 and WDR5 to the HIV-1 promoter. In agreement
with these results, PMA treatment released LSD1,
WDR5 and hSET1 from the viral promoter of HIV-1
infected cells (Figure 7C, columns 2, 4 and 5) and
decreased H3K4 trimethylation (Figure 7C column 3).
Taken together, our data suggest that LSD1-associated
increase of H3K4 trimethylation at the HIV-1 proximal
promoter region might be linked to hSET1 and WDR5
recruitment.
DISCUSSION
The introduction of HAART in 1996 has raised hopes for
curing patients infected with HIV-1. Unfortunately,
long-term suppression of HIV-1 replication has unveiled
the existence of latent HIV-1 reservoirs such as resting
CD4
+ T cells and monocytes/macrophages (25,38).
Microglial cells, the CNS-resident macrophages, are the
brain major targets for HIV-1 and constitute latently
infected cells (39). Understanding the molecular mechan-
isms of establishment, maintenance and reactivation of
HIV-1 latency in microglial cells is therefore crucial for ef-
ﬁcient therapeutic intervention (26,27). In recent papers,
we reported that CTIP2 inhibits HIV-1 replication and
transcription in microglial cells (29,30) by recruiting a
chromatin-modifying complex which contains histone de-
acetylases (HDAC1 and HDAC2) and a histone methyl-
tranferase (SUV39H1) (13). A better comprehension of
the molecular mechanisms involved in establishment and
maintenance of HIV-1 latency would be achieved by the
identiﬁcation of additional factors able to induce hetero-
chromatin formation at the viral promoter (26,31). Since
histone and DNA methylations have been implicated in
the silencing of the integrated provirus (12,13,40,41), we
further investigated the inﬂuence of speciﬁc demethylase
enzymes. LSD1, a demethylase ﬁrst identiﬁed by Shi et al.
(14) as a transcriptional repressor, constituted therefore a
potential candidate to play a role in HIV-1 silencing. In
this report, we ﬁrst showed that LSD1 represses HIV-1
expression by inhibiting the transcription step of the
viral life cycle. ChIP experiments revealed that LSD1 is
recruited to the HIV-1 proximal promoter. In addition,
the repressive epigenetic mark H3K9me3 was linked to
LSD1 recruitment at the viral promoter. Since LSD1
was initially characterized as a repressor associated with
demethylation of H3K4 (42), we focused our investigation
on this point. Surprisingly, we observed an increased
H3K4 trimethylation level in the HIV-1 proximal pro-
moter region upon LSD1 recruitment. Such a pattern
has previously been described in a previous work in the
context of the HSV promoter by Liang et al. (21).
However, these authors have further shown that this
H3K4 trimethylation correlated with a demethylation of
H3K9 and with transcriptional activation (21). Here, we
demonstrate for the ﬁrst time that LSD1-induced
Figure 6. CTIP2 recruitment on the HIV-1 proximal promoter requires LSD1. (A) ChIP experiments were performed on HEK 293T cells transfected
with the HIV-1 LTR LUC episomal vector in the presence of the pFLAG-LSD1, the pshRNA-LSD1 or the respective pcDNA3-FLAG and
pshRNA-control vectors. Cells were subjected to ChIP assays with the indicated antibodies. Speciﬁc enrichments in the HIV-1 proximal
promoter were quantiﬁed by real-time PCR targeting the Sp1-binding sites. Speciﬁc enrichments were calculated relative to the control IgG and
relative enrichments in the context of LSD1 over-expression or LSD1 depletion were expressed relative to the value obtained with the
pcDNA3-FLAG and the pshRNA-control vectors, respectively. Results were expressed relative to the value obtained with the episomal
LTR-LUC plasmid co-transfected with the pcDNA3-FLAG or the pshRNA-control vectors. (B) Control and CTIP2 knocked-down microglial
cells were infected with the VSV-pseudotyped pNL-4.3-Env virus 24h before being subjected to ChIP experiments with the indicated antibodies.
Speciﬁc enrichments were calculated relative to the control IgG and relative enrichments in the context of CTIP2 depletion were expressed relative to
the value obtained with the control cells. Speciﬁc enrichments at the HIV-1 proximal promoter were quantiﬁed by real-time PCR targeting the
LTR-Sp1-binding sites region.
1912 Nucleic Acids Research, 2012,Vol.40, No. 5transcriptional repression can be associated with both
H3K4me3 and H3K9me3 epigenetic marks. We further
show that these epigenetic marks are linked to LSD1 re-
cruitment at the HIV-1 proximal promoter through the
Sp1-binding sites as previously demonstrated for CTIP2
(13). Our results are in agreement with the model pre-
sented by the David Margolis group who demonstrated
that HDAC1 is released from the HIV-1 promoter upon
mutation of the Sp1-binding sites (37). Indeed, we demon-
strated that LSD1 and HDAC1 are associated with the
wild-type but not with the Sp1 mutated promoter. New
functional and biochemical investigations will be needed
to determine if these enzymes compete or cooperate for
their binding to the HIV-1 promoter. However, it is now
clear that both enzymes are involved in the silencing of
HIV-1 gene transcription.
We next evaluated whether two epigenetic marks,
H3K9me3 and H3K4me3, could result from LSD1
recruitment onto the HIV-1 promoter. Regarding
H3K9me3, we speculated that LSD1 could cooperate
with CTIP2 as we had previously shown that this factor
recruits SUV39H1, enzymes which speciﬁcally methylates
H3K9 (13). In agreement with this hypothesis, we showed
here that LSD1 cooperates functionally with CTIP2 to
repress HIV-1 replication and transcription in a synergis-
tic manner. We further demonstrated that this cooper-
ation correlates with a physical interaction between
CTIP2 and LSD1. ChIP assays showed that LSD1 and
CTIP2 interact physically, and confocal microscopy
experiments suggested an in vivo interaction between
these two proteins, which was found to occur in previously
characterized CTIP2-induced nuclear structures (30). In
addition, the transactivator Tat relocated LSD1 in the
nucleus. Since we believe that these ball-like nuclear struc-
tures reﬂect a heterochromatin environment, the co-
localization of LSD1 with both CTIP2 and Tat strongly
suggests that LSD1 is involved in promoting local hetero-
chromatin environment to repress HIV-1 gene transcrip-
tion in microglial cells. Moreover, LSD1 seems to have a
more critical role in promoting HIV-1 silencing than
CTIP2. Indeed, we showed that LSD1 is required for
CTIP2 recruitment onto the HIV-1 proximal promoter
whereas the reverse is not observed.
Mechanisms underlying LSD1-mediated increase of
H3K4 trimethylation might rather rely on LSD1 ability
to anchor other factors at the promoter than to its own
enzymatic activity. Indeed, LSD1 is also known to be
associated with the recruitment of hSET1 and WDR5,
two members of the hCOMPASS methyltransferase com-
plex, which is believed to induce the trimethylation of
H3K4 (43–46). In this context, LSD1, through its inter-
action with HCF-1, recruits this methyltransferase
complex containing WDR5 and hSET1 to the HSV
promoter (21). Here, we showed that LSD1 favours the
recruitment of such a complex to the HIV-1 promoter.
H3K4 trimethylation was associated with the recruitment
of LSD1, hSET1 and WDR5 at the Sp1-binding sites of
the HIV-1 LTR. Moreover, reactivation of HIV-1
Figure 7. LSD1 favours hSET1 and WDR5 recruitment at the HIV-1 proximal promoter. (A) ChIP experiments were performed on HEK 293T cells
transfected with the HIV-1 LTR-LUC episomal vector in the presence the pFLAG-LSD1, the pshRNA-LSD1 or the respective pcDNA3-FLAG and
pshRNA-control vectors. Cells were subjected to ChIP assays with the indicated antibodies. Speciﬁc enrichments were calculated relative to the
control IgG and relative enrichments in the context of LSD1 over-expression or depletion were expressed relative to the value obtained with the
pcDNA3-FLAG or the pshRNA-control vectors, respectively. Speciﬁc enrichments in the HIV-1 proximal promoter region were quantiﬁed by
real-time PCR. (B) HEK 293T cells were transfected with the pLTR-LUC (1–789) or with the pLTR-LUC (1–789) mut Sp1 vector 48h before
being subjected to ChIP experiments with the indicated antibodies. Input and immunoprecipitated DNAs were quantiﬁed by real-time PCR using
primers targeting the Sp1-binding sites region of the HIV-1 promoter. The amounts of immunoprecipitated material were normalized to the input
DNA and presented relative to the non speciﬁc control IgG. (C) Microglial cells were infected with the VSV-pseudotyped pNL4.3-Env virus 24h
before being subjected to ChIP experiments with the indicated antibodies. Speciﬁc enrichments in the HIV-1 proximal promoter were quantiﬁed by
real-time PCR. Enrichments are presented relative to the non speciﬁc IgG values set at 1.
Nucleic Acids Research,2012, Vol.40, No. 5 1913proviruses correlated with the release of LSD1, hSET1
and WDR5 from the viral promoter and with a reduced
H3K4 trimethylation. All together, our results strongly
suggest that LSD1 is involved in the establishment and
the maintenance of HIV-1 latency in microglial cells by
favouring a local heterochromatin structure.
Association of both H3K4me3 and H3K9me3 epigene-
tic marks with LSD1 recruitment may thus constitute a
new level of eukaryotic gene regulation. These observa-
tions are consistent with the discovery that H3K4 methy-
lation at certain chromatin loci may prevent gene
expression (11). Interestingly, such a gene repression
linked to H3K4me3 has been proposed to prevent the ex-
pression of cryptic promoters (5,11). This is strengthened
by the ﬁndings that HIV-1 preferentially integrates in
active genes and therefore could be considered as a
cryptic gene. Additional mechanisms including transcrip-
tional interference are believed to prevent expression of
such cryptic promoters (47). It could be argued that
H3K4me3 is already present on the HIV-1 promoter
upon integration into the host cell genome as it integrates
into active genes enriched with euchromatic histone modi-
ﬁcations such as H3K4 methylation and histones acetyl-
ation (48). The subsequent silencing characterized by
H3K9me3 would then occur through LSD1-mediated re-
cruitment of the CTIP2-HDAC-SUV39H1 complex.
However, the fact that both H3K4me3 and H3K9me3
were lost following reactivation in association with the
release of LSD1 from the HIV-1 promoter argues that,
at least in the context of HIV-1 promoter, these two epi-
genetic marks are associated with transcriptional repres-
sion and favour the establishment and the maintenance of
latency.
The exact mechanisms underlying LSD1 function in
HIV-1 repression are complex and far to be elucidated.
Although we showed in this report that LSD1 interacts
physically and cooperates functionally with CTIP2, it
remains to be determined whether all the components re-
cruited to the HIV-1 promoter are in the same complex or
whether they interact with LSD1 independently. Even if
the exact mechanisms by which LSD1 promotes a local
heterochromatin structure remain unknown, LSD1 consti-
tutes a new target for potential therapeutic strategies
aiming at purging the HIV-1 latent reservoirs.
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